• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SPP1 通过驱动 M2 巨噬细胞浸润促进食管鳞癌的进展,代表了一个治疗靶点。

SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration.

机构信息

Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450052, Henan, China.

Department of Nuclear Medicine, Xinxiang Central Hospital, Xinxiang, 453002, Henan, China.

出版信息

Br J Cancer. 2024 May;130(11):1770-1782. doi: 10.1038/s41416-024-02683-x. Epub 2024 Apr 10.

DOI:10.1038/s41416-024-02683-x
PMID:38600327
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11130281/
Abstract

BACKGROUND

Tumour-associated macrophages (TAMs) are an important component of the tumour microenvironment (TME). However, the crosstalk between oesophageal squamous cell carcinoma (ESCC) cells and TAMs remains largely unexplored.

METHODS

Clinical samples and the TCGA database were used to evaluate the relevance of SPP1 and TAM infiltration in ESCC. Mouse models were constructed to investigate the roles of macrophages educated by SPP1 in ESCC. Macrophage phenotypes were determined using qRT‒PCR and immunohistochemical staining. RNA sequencing was performed to elucidate the mechanism.

RESULTS

Increasing expression of SPP1 correlated with M2-like TAM accumulation in ESCC, and they both predicted poor prognosis in the ESCC cohort. Knockdown of SPP1 significantly inhibited the infiltration of M2 TAMs in xenograft tumours. In vivo mouse model experiments showed that SPP1-mediated education of macrophages plays an essential role in the progression of ESCC. Mechanistically, SPP1 recruited macrophages and promoted M2 polarisation via CD44/PI3K/AKT signalling activation and then induced VEGFA and IL6 secretion to sustain ESCC progression. Finally, blockade of SPP1 with RNA aptamer significantly inhibited tumour growth and M2 TAM infiltration in xenograft mouse models.

CONCLUSIONS

This study highlights SPP1-mediated crosstalk between ESCC cells and TAMs in ESCC. SPP1 could serve as a potential target in ESCC therapy.

摘要

背景

肿瘤相关巨噬细胞(TAMs)是肿瘤微环境(TME)的重要组成部分。然而,食管鳞状细胞癌(ESCC)细胞与 TAMs 之间的串扰在很大程度上仍未得到探索。

方法

使用临床样本和 TCGA 数据库评估 SPP1 和 TAM 浸润在 ESCC 中的相关性。构建小鼠模型以研究由 SPP1 教育的巨噬细胞在 ESCC 中的作用。使用 qRT-PCR 和免疫组织化学染色来确定巨噬细胞表型。进行 RNA 测序以阐明机制。

结果

SPP1 表达增加与 ESCC 中 M2 样 TAM 积累相关,并且它们都在 ESCC 队列中预测预后不良。SPP1 的敲低显著抑制了异种移植肿瘤中 M2 TAM 的浸润。体内小鼠模型实验表明,SPP1 介导的巨噬细胞教育在 ESCC 的进展中起着至关重要的作用。从机制上讲,SPP1 通过 CD44/PI3K/AKT 信号通路的激活招募巨噬细胞并促进 M2 极化,然后诱导 VEGFA 和 IL6 的分泌以维持 ESCC 的进展。最后,用 RNA 适体阻断 SPP1 可显著抑制异种移植小鼠模型中的肿瘤生长和 M2 TAM 浸润。

结论

这项研究强调了 SPP1 在 ESCC 中在 ESCC 细胞与 TAMs 之间的串扰。SPP1 可作为 ESCC 治疗的潜在靶点。

相似文献

1
SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration.SPP1 通过驱动 M2 巨噬细胞浸润促进食管鳞癌的进展,代表了一个治疗靶点。
Br J Cancer. 2024 May;130(11):1770-1782. doi: 10.1038/s41416-024-02683-x. Epub 2024 Apr 10.
2
SUMO modified ETV1 promotes M2-polarized tumor-associated macrophage infiltration and cancer progression by facilitating CCL2 transcription in esophageal squamous cell carcinoma cells.SUMO修饰的ETV1通过促进食管鳞状细胞癌细胞中CCL2的转录,促进M2极化的肿瘤相关巨噬细胞浸润和癌症进展。
Cancer Immunol Immunother. 2025 Feb 1;74(3):87. doi: 10.1007/s00262-024-03914-z.
3
FOXO1 promotes tumor progression by increased M2 macrophage infiltration in esophageal squamous cell carcinoma.FOXO1 通过增加食管鳞状细胞癌中的 M2 巨噬细胞浸润促进肿瘤进展。
Theranostics. 2020 Sep 16;10(25):11535-11548. doi: 10.7150/thno.45261. eCollection 2020.
4
CCL2-CCR2 axis recruits tumor associated macrophages to induce immune evasion through PD-1 signaling in esophageal carcinogenesis.CCL2-CCR2 轴通过 PD-1 信号招募肿瘤相关巨噬细胞诱导免疫逃逸在食管癌变中。
Mol Cancer. 2020 Feb 27;19(1):41. doi: 10.1186/s12943-020-01165-x.
5
Oesophageal squamous cell carcinoma-associated IL-33 rewires macrophage polarization towards M2 via activating ornithine decarboxylase.食管鳞状细胞癌相关的 IL-33 通过激活鸟氨酸脱羧酶将巨噬细胞极化转向 M2。
Cell Prolif. 2021 Feb;54(2):e12960. doi: 10.1111/cpr.12960. Epub 2020 Dec 10.
6
LINC00330/CCL2 axis-mediated ESCC TAM reprogramming affects tumor progression.LINC00330/CCL2 轴介导的 ESCC TAM 重编程影响肿瘤进展。
Cell Mol Biol Lett. 2024 May 20;29(1):77. doi: 10.1186/s11658-024-00592-8.
7
SPP1-mediated M2 macrophage polarization shapes the tumor microenvironment and enhances prognosis and immunotherapy guidance in nasopharyngeal carcinoma.SPP1介导的M2巨噬细胞极化塑造肿瘤微环境并改善鼻咽癌的预后及免疫治疗指导。
Int Immunopharmacol. 2025 Feb 6;147:113944. doi: 10.1016/j.intimp.2024.113944. Epub 2024 Dec 31.
8
Downregulation of RCN1 inhibits esophageal squamous cell carcinoma progression and M2 macrophage polarization.下调 RCN1 抑制食管鳞癌细胞的进展和 M2 巨噬细胞极化。
PLoS One. 2024 May 7;19(5):e0302780. doi: 10.1371/journal.pone.0302780. eCollection 2024.
9
Macrophage Infiltration and ITGB2 Expression in ESCC: A Novel Correlation.巨噬细胞浸润与整合素β2(ITGB2)在食管癌中的表达:一种新的相关性
Cancer Med. 2025 Jan;14(2):e70604. doi: 10.1002/cam4.70604.
10
PYCR1 Promotes Esophageal Squamous Cell Carcinoma by Interacting With EGFR to Affecting the PI3K/Akt/mTOR Signaling Pathway.PYCR1通过与表皮生长因子受体(EGFR)相互作用影响PI3K/Akt/mTOR信号通路来促进食管鳞状细胞癌。
J Gene Med. 2025 Mar;27(3):e70017. doi: 10.1002/jgm.70017.

引用本文的文献

1
Cellular senescence in colorectal cancer: its occurrence, effect and therapy.结直肠癌中的细胞衰老:其发生、影响及治疗
Front Oncol. 2025 Aug 15;15:1580951. doi: 10.3389/fonc.2025.1580951. eCollection 2025.
2
Identification of CTSC-driven progression in ESCC by single-cell sequencing and experimental validation.通过单细胞测序和实验验证鉴定CTSC驱动的食管鳞状细胞癌进展
Front Immunol. 2025 Jul 16;16:1585139. doi: 10.3389/fimmu.2025.1585139. eCollection 2025.
3
Macrophage Signaling Pathways in Health and Disease: From Bench to Bedside Applications.健康与疾病中的巨噬细胞信号通路:从实验室到临床应用
MedComm (2020). 2025 Jun 16;6(7):e70256. doi: 10.1002/mco2.70256. eCollection 2025 Jul.
4
Decoding meningioma prognosis with multi-omics: macrophage diversity, immune-CNV interplay, and novel SPP1-targeted strategies.利用多组学技术解码脑膜瘤预后:巨噬细胞多样性、免疫-拷贝数变异相互作用及新型SPP1靶向策略
J Neurooncol. 2025 Jun 16. doi: 10.1007/s11060-025-05116-8.
5
The Landscape of SPP1 Macrophages Across Tissues and Diseases: A Comprehensive Review.跨组织和疾病的SPP1巨噬细胞全景:综述
Immunology. 2025 Oct;176(2):179-196. doi: 10.1111/imm.13952. Epub 2025 May 21.
6
Spatially segregated APOE macrophages restrict immunotherapy efficacy in clear cell renal cell carcinoma.空间隔离的载脂蛋白E巨噬细胞限制了透明细胞肾细胞癌的免疫治疗效果。
Theranostics. 2025 Apr 13;15(11):5312-5336. doi: 10.7150/thno.109097. eCollection 2025.
7
Decoding SPP1 regulation: Genetic and nongenetic insights into its role in disease progression.解码SPP1调控:对其在疾病进展中作用的遗传和非遗传见解。
Mol Cells. 2025 Apr 8;48(6):100215. doi: 10.1016/j.mocell.2025.100215.
8
Characterizing macrophage diversity in colorectal malignancies through single-cell genomics.通过单细胞基因组学表征结直肠癌中的巨噬细胞多样性。
Front Immunol. 2025 Mar 21;16:1526668. doi: 10.3389/fimmu.2025.1526668. eCollection 2025.
9
SPP1 as a Prognostic and Immunotherapeutic Biomarker in Gliomas and Other Cancer Types: A Pan-Cancer Study.SPP1作为神经胶质瘤和其他癌症类型的预后及免疫治疗生物标志物:一项泛癌研究
J Inflamm Res. 2025 Feb 13;18:2247-2265. doi: 10.2147/JIR.S505237. eCollection 2025.
10
VSIG4 tumor-associated macrophages mediate neutrophil infiltration and impair antigen-specific immunity in aggressive cancers through epigenetic regulation of SPP1.VSIG4肿瘤相关巨噬细胞通过对SPP1的表观遗传调控介导中性粒细胞浸润,并损害侵袭性癌症中的抗原特异性免疫。
J Exp Clin Cancer Res. 2025 Feb 7;44(1):45. doi: 10.1186/s13046-025-03303-z.

本文引用的文献

1
Biological and clinical significance of the YKL-40/osteopontin-integrin β4-p70S6K axis induced by macrophages in early oesophageal squamous cell carcinoma.巨噬细胞诱导的早期食管鳞癌中 YKL-40/骨桥蛋白-整合素 β4-p70S6K 轴的生物学和临床意义。
J Pathol. 2023 Sep;261(1):55-70. doi: 10.1002/path.6148. Epub 2023 Jul 12.
2
Macrophages in immunoregulation and therapeutics.巨噬细胞在免疫调节和治疗中的作用。
Signal Transduct Target Ther. 2023 May 22;8(1):207. doi: 10.1038/s41392-023-01452-1.
3
Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation.鉴定食管鳞癌中 TREM2 阳性肿瘤相关巨噬细胞:对预后不良和免疫治疗调节的意义。
Front Immunol. 2023 Apr 28;14:1162032. doi: 10.3389/fimmu.2023.1162032. eCollection 2023.
4
Macrophage Polarization: An Important Candidate Regulator for Lung Diseases.巨噬细胞极化:肺部疾病的重要候选调控因子
Molecules. 2023 Mar 4;28(5):2379. doi: 10.3390/molecules28052379.
5
Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer.发现和评估浆液性卵巢癌中最稳健的预后生物标志物。
Geroscience. 2023 Jun;45(3):1889-1898. doi: 10.1007/s11357-023-00742-4. Epub 2023 Mar 1.
6
The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy.固有免疫细胞在肿瘤微环境中的作用及抗肿瘤治疗的研究进展。
Front Immunol. 2023 Jan 19;13:1039260. doi: 10.3389/fimmu.2022.1039260. eCollection 2022.
7
Phosphorylation of TGIF2 represents a therapeutic target that drives EMT and metastasis of lung adenocarcinoma.TGIF2 的磷酸化代表了一个治疗靶点,它驱动肺腺癌的 EMT 和转移。
BMC Cancer. 2023 Jan 16;23(1):52. doi: 10.1186/s12885-023-10535-9.
8
Multi-Transcriptomic Analysis Reveals the Heterogeneity and Tumor-Promoting Role of SPP1/CD44-Mediated Intratumoral Crosstalk in Gastric Cancer.多转录组分析揭示了SPP1/CD44介导的胃癌瘤内串扰的异质性和促肿瘤作用
Cancers (Basel). 2022 Dec 27;15(1):164. doi: 10.3390/cancers15010164.
9
Neoadjuvant immunotherapy for resectable esophageal cancer: A review.新辅助免疫治疗可切除食管癌:综述。
Front Immunol. 2022 Dec 8;13:1051841. doi: 10.3389/fimmu.2022.1051841. eCollection 2022.
10
Targeting macrophages: a novel treatment strategy in solid tumors.靶向巨噬细胞:实体瘤治疗的新策略。
J Transl Med. 2022 Dec 12;20(1):586. doi: 10.1186/s12967-022-03813-w.